Evidence map›Paper›PMID 37696977›Full record

ArticleScientific reports2023

Antioxidant activity and mineral content of Impatiens tinctoria A. Rich (Ensosila) tuber, an Ethiopian medicinal plant.

Gizachew Haile Gidamo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Biosynthesis of TiOACS omega · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gizachew Haile GidamoBiotechnology and Bioprocess Centre of Excellence, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia. gizachew.haile@aastu.edu.et.
Addis Ababa Science and Technology University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, an interest has surged in incorporating extracts of medicinal plants as active ingredients in cosmetic formulations, highlighting the need to analyze medicinal plants of cosmetic interest for phytochemicals and bioactivities. The tuber of the Ethiopian medicinal plant Impatiens tinctoria A. Rich (Ensosila) is used to make traditional cosmetics. The aim of the study was to investigate the antioxidant and mineral content of the Impatiens tinctoria tuber. Water, ethanol, and methanol were used during the extraction process. High phenolic content was found in methanol extract (107.8 ± 0.025 µg/ml GAE) followed by water extract (92.4 ± 0.02 µg/ml GAE). High flavonoid content was also obtained in methanol extract (136.7 ± 0.04 µg/ml QE). Strong 2,2-diphenyl-1-picryl-hydrazyl (DPPH) scavenging activity was recorded for methanol extract with IC50 value of 44.4 µg/ml, compared with ethanol extract (97.54 µg/ml) and water extracts (98.24 µg/ml). The lower IC50 value of methanolic extract demonstrated strong antioxidant activity. The three elements that were most prevalent in Impatiens tinctoria tuber out of the eight elements examined were K (170 ± 0.05 mg/100 g sample), Ca (87 ± 0.08 mg/100 g sample), and Mg (16 ± 0.01 mg/100 g sample). The phenolics, flavonoids, and minerals found in Impatiens tinctoria A. Rich (Ensosila) tuber may protect against oxidative stress-related skin damage and thus deserving attention for future applications in cosmetics formulations.

Indexed as

ImpatiensPlants, MedicinalAntioxidantsEthanolFlavonoidsMethanolMineralsPhenolsWaterAntioxidantsEthanolFlavonoidsMethanolMineralsPhenolsWater

Identifiers

PMID37696977
PMCPMC10495335
OpenAlexW4386610177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.